NEUBASE THERAPEUTICS INC (64132K201) Institutional Ownership

64132K201 is currently held by 1 institutional investors tracked by InsiderSet, with a combined reported market value of approximately $100,912 based on the latest available SEC Form 13F filings for the quarter ended December 31, 2023.

The largest disclosed holder is Greenlight Capital, which reported ownership valued at approximately $100,912 in its December 31, 2023 13F filing.

Major shareholders tracked on this page include Greenlight Capital, and other prominent asset managers. Collectively, these investors account for approximately 100% of the total disclosed value among the investors covered in this analysis.

This page tracks fund ownership trends, hedge fund exposure, portfolio concentration, historical 13F filings, and estimated holding performance to help investors analyze smart money sentiment toward NEUBASE THERAPEUTICS INC (64132K201).